Fawcett leads a team of communicators who produce targeted, innovative communication for the Rogel Cancer Center’s research and clinical enterprises. Prior to Michigan Medicine, Fawcett was a reporter at the Detroit News and editor for a web-based community for people with disabilities.
Clinical trials underway are testing whether drugs that target the androgen receptor – successful in controlling prostate cancer – could also work against the coronavirus.
Implementing policies and strategies to eliminate racial disparities could improve outcomes for both diseases.
New research suggests the thought of being a protector overrides desire for personal freedoms when it comes to COVID-safety messages.
A new study finds that significant symptoms in young and Black patients are more likely to be under-recognized.
A first-ever report describes how overall gains against cancer are not benefiting some racial and ethnic groups – and how COVID-19 may be making it worse.
A new study shows tumor cells eat up a key amino acid, depriving immune cells of it, which prevents them from fighting off cancer.
